Pfizer (PFE - Research Report) received a Buy rating and a $55.00 price target from Credit Suisse analyst Trung Huynh today. The company's shares closed yesterday at $49.08.According to TipRanks, Huynh is a 5-star analyst with an average return of 12.4% and a 77.63% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Pfizer, Amgen, and Bristol Myers.Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $52.00.See Insiders’ Hot Stocks on TipRanks >> Based on Pfizer's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $22.64 billion and a net profit of $8.
https://www.tipranks.com/news/blurbs/positive-report-for-pfizer-pfe-from-credit-suisse?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 1 2023 まで 2 2023 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 2 2022 まで 2 2023 Pfizerのチャートをもっと見るにはこちらをクリック